You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR COCAINE HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for cocaine hydrochloride

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000187 ↗	Ritanserin in Treatment of Cocaine Dependence - 1	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1992-07-01	The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.
NCT00000187 ↗	Ritanserin in Treatment of Cocaine Dependence - 1	Completed	University of Pennsylvania	Phase 2	1992-07-01	The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.
NCT00000188 ↗	Selegiline in Treatment of Cocaine Dependence - 2	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1994-09-01	The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence.
NCT00000188 ↗	Selegiline in Treatment of Cocaine Dependence - 2	Completed	University of Pennsylvania	Phase 2	1994-09-01	The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence.
NCT00000189 ↗	Gepirone vs Placebo in Treatment of Cocaine Dependence - 3	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1990-01-01	The purpose of this study is to test antidepressant medication, gepirone, as a pharmacotherapy for cocaine dependent subjects.
NCT00000189 ↗	Gepirone vs Placebo in Treatment of Cocaine Dependence - 3	Completed	University of Pennsylvania	Phase 2	1990-01-01	The purpose of this study is to test antidepressant medication, gepirone, as a pharmacotherapy for cocaine dependent subjects.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for cocaine hydrochloride

Condition Name

Chart
Table

Condition Name for cocaine hydrochloride
Intervention	Trials
Cocaine-Related Disorders	141
Cocaine Dependence	138
Cocaine Use Disorder	35
Cocaine Abuse	26
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for cocaine hydrochloride
Intervention	Trials
Cocaine-Related Disorders	315
Disease	79
Substance-Related Disorders	55
Opioid-Related Disorders	40
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for cocaine hydrochloride

Trials by Country

Map
Table

Trials by Country for cocaine hydrochloride
Location	Trials
United States	526
Canada	11
Spain	9
Brazil	9
Switzerland	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for cocaine hydrochloride
Location	Trials
Texas	71
New York	52
Pennsylvania	52
Connecticut	47
California	40
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for cocaine hydrochloride

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for cocaine hydrochloride
Clinical Trial Phase	Trials
Phase 4	29
Phase 3	30
Phase 2/Phase 3	17
[disabled in preview]	325
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for cocaine hydrochloride
Clinical Trial Phase	Trials
Completed	343
Recruiting	31
Terminated	30
[disabled in preview]	66
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for cocaine hydrochloride

Sponsor Name

Chart
Table

Sponsor Name for cocaine hydrochloride
Sponsor	Trials
National Institute on Drug Abuse (NIDA)	304
Yale University	49
New York State Psychiatric Institute	43
[disabled in preview]	79
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for cocaine hydrochloride
Sponsor	Trials
Other	550
NIH	319
Industry	43
[disabled in preview]	31
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.